+86(1812)4514114 info@phcoker.com

Raw Glatiramer Acetate powder (147245-92-9)

Glatiramer Acetate powder (147245-92-9) is a synthetic protein that simulates myelin basic protein, a component of the……


Status: In Mass Production
Synthesized and Customized Available
Capacity: 1277kg/month

 

Description

Raw Glatiramer Acetate powder (147245-92-9) video

 

Raw Glatiramer Acetate powder (147245-92-9) Description

Glatiramer Acetate powder (147245-92-9) is a synthetic protein that simulates myelin basic protein, a component of the myelin that insulates nerve fibers in the brain and spinal cord. This drug seems to block myelin-damaging T-cells through a mechanism that is not completely understood.

Raw Glatiramer Acetate powder (147245-92-9) injection is approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with relapsing forms of multiple sclerosis.

Raw Glatiramer Acetate powder (147245-92-9) Specifications

Product Name Glatiramer acetate
Chemical Name (S)-2,6-diaminohexanoic acid compound with(S)-2-amino-3-(4-hydroxyphenyl)propanoic acid and (S)-2-aminopentanedioic acid and (S)-2-aminopropanoic acid and acetic acid (1:1:1:1:1)
Brand Name Copaxone (Teva).
Drug Class Peptide
CAS Number 147245-92-9
InChIKey FHEAIOHRHQGZPC-KIWGSFCNSA-N
Molecular Formula C25H45N5O13
Molecular Weight 623.6505
Monoisotopic Mass 623.65
Melting Point  N/A
Biological Half-Life N/A
Color White
Solubility  <6.24mg/mL in DMSO
Storage Temperature  −20°C
Application GA treatment led to sustained augmentation of the expression of BDNF, NT-3, and NT-4 in various brain regions.

 


=

References & product citations